Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - May 2014


PharmAccess Leaders Forum

19 May 2014 - 21 May 2014 - Paris, France



Bookmark and Share


NextLevel Pharma’s PharmAccess Leaders Forum is quickly becoming THE “must attend” event for senior representatives of the market access community in Europe. With over 30 senior-level speakers from Payers, HTAs, Hospitals, stakeholder groups, and not to mention the pharmaceutical industry, more than 100 participants will attend. Attendees will achieve the most relevant learning, benchmarking and networking experience available for senior executives who are involved in patient access, health economics, outcomes, pricing and reimbursement. 3 EVENTS IN ONE: 1. Innovative Pricing & Reimbursement Agreements 2. Achieving Market Access for High-Value Oncology Therapeutics 3. Best Practices in Economic Modeling to Demonstrate Superior Outcomes & Value This year’s “Spring Edition” in Paris, will focus the audience on the necessary steps to achieving rapid market access, through enhanced value-demonstration, whilst delivering as much certainty as possible for payers, as well as delivering the patient with the most innovative & beneficial products possible. Request agenda at http://springpharmaccess2014.nextlevelpharma.com/request-agenda or contact me directly for more information. We look forward to meeting you in Paris!

Further information
Scientific News
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Growing Stem Cells More Safely
Nurturing stem cells atop a bed of mouse cells works well, but is a non-starter for transplants to patients – Brown University scientists are developing a synthetic bed instead.
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Designing Better Drugs
A rational drug engineering approach could breathe new life into drug development.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Potential Target for Revolutionary Antibiotics
An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!